Email ID
Password
Scrip   
Carisoprodol targeted for controlled substance restrictions in US
26 November 2009
Sue Sutter

The US Drug Enforcement Administration (DEA) has proposed classifying carisoprodol, a long-available muscle relaxant, as a schedule IV controlled substance owing to its abuse potential.
Carisoprodol is indicated for relief of discomfort associated with acute, painful musculoskeletal conditions....



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36